GlassScriptPhysician profile
Benjamin R Davis
NPI 1609247477
$8,475.33
in general payments reported to CMS, 2019-2025
46 companies · $2,411 in 2025
The $2,411 reported for 2025 was more than what 93% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $621 · 2022: $1,200 · 2023: $2,171 · 2024: $2,072 · 2025: $2,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,568 · Education: $86.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,567.67 |
| Education | $86.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,113.20 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,016.33 | 2021-2025 | Ofev, Jardiance, Spiriva Respimat |
| Abbvie INC. | $630.20 | 2021-2025 | |
| Lilly USA, LLC | $606.72 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Merck Sharp & Dohme LLC | $473.11 | 2021-2025 | Winrevair, Dificid, Belsomra |
| Novo Nordisk INC | $446.76 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Regeneron Healthcare Solutions, INC. | $416.11 | 2021-2025 | Dupixent |
| Amgen INC. | $364.14 | 2022-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $323.73 | 2022-2025 | Tezspire, Fasenra, Farxiga |
| United Therapeutics Corporation | $268.10 | 2022-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $246.58 | 2022-2024 | Yupelri |
| Abiomed | $227.27 | 2022-2024 | Impella |
| Pfizer INC. | $222.65 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $163.37 | 2023-2025 | Glassia |
| Genzyme Corporation | $163.13 | 2021-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $157.52 | 2025 | Voquezna |
| Viatris Specialty LLC | $152.11 | 2025 | Yupelri |
| Abbott Laboratories | $132.43 | 2022-2025 | Freestyle Libre 3 |
| Electromed, INC. | $132.39 | 2021-2024 | Smartvest |
| Verona Pharma, INC. | $130.98 | 2025 | Ohtuvayre |
| Baxter Healthcare | $107.71 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $83.00 | 2022-2025 | Prolastin-C Liquid |
| Boston Scientific Corporation | $82.64 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Paratek Pharmaceuticals, INC. | $77.04 | 2024-2025 | Nuzyra |
| Vifor Pharma, INC. | $72.60 | 2024 | Zemaira, Veltassa |
| Actelion Pharmaceuticals US, INC. | $69.26 | 2021-2025 | Uptravi, Opsumit |
| Ani Pharmaceuticals, INC. | $62.38 | 2025 | Purified Cortrophin Gel |
| E.R. Squibb & Sons, L.L.C. | $52.75 | 2021-2023 | Eliquis |
| Novartis Pharmaceuticals Corporation | $49.11 | 2022-2023 | |
| Exact Sciences Corporation | $48.89 | 2023-2025 | Cologuard Collection Kit |
| Philips North America LLC | $43.21 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Idorsia Pharmaceuticals US INC | $42.14 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $40.83 | 2023 | Sunosi |
| Aimmune Therapeutics, INC. | $33.21 | 2024-2025 | Vowst |
| Pulmonx Corporation | $23.66 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Medtronic, INC. | $23.65 | 2022 | |
| Nabriva Therapeutics, Plc | $22.25 | 2022 | |
| Hologic Sales and Service, LLC | $20.64 | 2022 | |
| Exeltis, USA INC. | $20.60 | 2023 | Slynd |
| Janssen Biotech, INC. | $20.16 | 2024 | Stelara |
| Insmed, INC. | $19.62 | 2025 | Arikayce |
| Ultragenyx Pharmaceutical INC. | $16.97 | 2023 | Crysvita |
| Sumitomo Pharma America, INC. | $15.18 | 2024 | Gemtesa |
| Edwards Lifesciences Corporation | $14.86 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Seqirus USA INC | $13.48 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Janssen Pharmaceuticals, INC | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.